News Room

  • PKU Gap Research – PKU Qualitative Research – for ages 18-55

    PKU Gap Research – PKU Qualitative Research – for ages 18-55

    Newborn screening for Phenylketonuria has been in place in Australia for over 50 years. Our research team are currently conducting a study hoping to understand patient outcomes and the lived […]

    Read More

  • BREAKING NEWS: The Power of Advocacy a win for equitable treatment for the PKU Community

    BREAKING NEWS: The Power of Advocacy a win for equitable treatment for the PKU Community

    The Power of Advocacy a win for equitable treatment for the PKU Community  Metabolic Dietary Disorders Association and PKUNSW Association are extremely pleased with the decision of the Pharmaceutical Benefits […]

    Read More

  • UPDATE: The PBAC Outcome

    UPDATE: The PBAC Outcome

    As we wait for the August announcement on the PBAC meeting outcome to list sapropterin (Kuvan) & pegvaliase (Palynziq) on the PBS we would like to share with you 3 […]

    Read More

  • 2022 MDDA National Family Retreat – Registrations now OPEN!

    2022 MDDA National Family Retreat – Registrations now OPEN!

    THE WAIT IS OVER! Registrations for the MDDA Retreat are now OPEN! MDDA’s National Family Retreat is our hallmark event that usually occurs once a year in a prime interstate […]

    Read More

  • MDDA Community Announcement

    MDDA Community Announcement

    Pharmaceutical Benefits Scheme Safety Net threshold reduction from 1 July 2022 As a cost-of-living measure, the Australian Government is lowering the PBS Safety Net thresholds from 1 July 2022 by […]

    Read More

  • The Great Protein Challenge 2022 Launch

    The Great Protein Challenge 2022 Launch

    How #lowpro Can You Go? This May we will once again be running The Great Protein Challenge, a national effort where challengers strive to eat under 10 grams of protein […]

    Read More

  • MDDA Announcement: Ensuring treatment access for all Australians with PKU

    MDDA Announcement: Ensuring treatment access for all Australians with PKU

    MDDA Announcement: Ensuring treatment access for all Australians with PKU 30 March 2022 Today (Wednesday, 30 March), the Pharmaceutical Benefits Advisory Committee (PBAC) published the agenda for its next meeting, […]

    Read More

  • Flood Assistance for IEM Families

    Flood Assistance for IEM Families

    MDDA sympathises with all of those affected by the catastrophic floods in Queensland and New South Wales.  We encourage any IEM families seeking assistance to contact the MDDA directly at […]

    Read More

  • Low Protein Product Supply – Update 2022

    Low Protein Product Supply – Update 2022

    MDDA’s highest priority during these times is to make sure that the IEM community has the most accurate and up-to-date information when it comes to supply of low protein food, […]

    Read More

Newsletter Archives

Browse through our library of previous MDDA Matters printed newsletters and click on the image to read or download